Antibiotice
↗Iași, Romania
Romania's largest and oldest pharmaceutical manufacturer, founded in 1955 as the first penicillin producer in South-Eastern Europe. Antibiotice is a strategic pharmaceutical company specializing in generic medicines and active pharmaceutical ingredients (APIs). The company produces over 150 medicines across 12 therapeutic areas including anti-infectives, cardiovascular, CNS, dermatological, and gynecological preparations. Notably, Antibiotice is the world leader in Nystatin (antifungal) production, holding 50% of the global market share and producing the USP reference standard for Nystatin. The company operates state-of-the-art GMP-certified manufacturing facilities with 9 production lines and exports to over 60 countries globally.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Generic Medicines, Active Pharmaceutical Ingredients
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$130M-$150M
Founded:1955
Ownership:public
Status:operating
FUNDING
Stage:Public Company
Investors:Romanian Ministry of Health (53.02% ownership), Infinity Capital Investments (13%), Other public shareholders
STOCK
Exchange:BVB (Bucharest Stock Exchange)
Ticker:ATB
Market Cap:$352M
PIPELINE
Stage:Commercial
Lead Drug Stage:Multiple approved/commercial products
Modalities:Small molecule, Injectable sterile powders, Capsules, Tablets, Ointments, Gels, Creams, Active Pharmaceutical Ingredients (APIs)
Active Trials:0
Trial Phases:-
FDA Approvals:6
CORPORATE STRUCTURE
Key Partnerships:European Investment Bank (EIB) - financing and advisory support for generic drug production, IBM - SAP S/4HANA digital modernization initiative (2024), Enel X - solar park development (2.5 MW photovoltaic project)
COMPETITION
Position:Leader
Competitors:Gedeon Richter (Hungary), Sandoz (Switzerland/Global), Teva Pharmaceutical (Israel/Global), Hexal (Germany), Other Romanian generic producers
LEADERSHIP
Key Executives:
Lucian Timofticiuc - President of Management Board
Ioan Nani - Chief Executive Officer (CEO) / Executive Vice Chairman
Gianina Macovei - Executive Director, Research & Development
Paula Coman - Economic/Financial Director
Cornelia Moraru - Technical and Production Director
Board Members:Lucian Timofticiuc (President), Ioan Nani (Vice-President/CEO), 5 additional board members (names not fully disclosed in public sources)
LINKS
Website:antibiotice.ro
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Antibiotice and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Antibiotice. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.